Panome Bio Inc. — Form D
Panome Bio Inc. of SAINT LOUIS, MO, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-24. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-02-24
- Form: D
- Accession: 0001966691-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.0M
- Amount sold: $6.0M
- Minimum investment: $20K
- Investors: 6
- Date of first sale: 2023-02-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-474235
Issuer
- Name: Panome Bio Inc.
- CIK: 0001966691
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 4340 DUNCAN AVENUE, SAINT LOUIS, MO, 63110
- Phone: 3144774334
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Alexander Herzick | Director | Salt Lake City, UT |
| David Smoller | Director | St. Louis, MO |
| Tom Cohen | Executive Officer | St. Louis, MO |
| Rob Capone | Director | St. Louis, MO |
| Edward Weinstein | Director | St. Louis, MO |
| Edward Weinstein | Executive Officer | St. Louis, MO |
| Deval Lashkari | Director | San Francisco, CA |
Other filings by this issuer (1)
More